Genesis Medtech Surgical Instrument Patent US12605179B2
Summary
USPTO granted patent US12605179B2 to Genesis Medtech (USA) Inc. on April 21, 2026 for ultrasonic surgical instruments with translational capability. The patent covers an ultrasonic waveguide selectively coupleable within the transducer assembly to provide at least two different effective lengths without altering the resonant frequency of the instrument. The patent contains 20 claims.
What changed
USPTO granted patent US12605179B2 to Genesis Medtech (USA) Inc. for ultrasonic surgical instruments with translational capability. The invention allows a waveguide to be selectively coupled within an ultrasonic transducer to provide at least two different effective lengths without changing the instrument's resonant frequency.
Manufacturers of ultrasonic surgical instruments should be aware of this newly granted patent as it may affect product development decisions. Competitors seeking to design similar variable-length ultrasonic surgical instruments may need to evaluate potential licensing needs or design-around strategies to avoid infringement of the granted claims.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Ultrasonic surgical instruments with translational capability
Grant US12605179B2 Kind: B2 Apr 21, 2026
Assignee
Genesis Medtech (USA) Inc.
Inventors
Shan Wan, Brendan Reimer
Abstract
An ultrasonic surgical instrument having an ultrasonic resonant frequency when operatively connected to an ultrasonic generator, the surgical instrument including an ultrasonic transducer assembly adapted for converting electrical energy into longitudinal vibrational motion at an ultrasonic frequency, the transducer assembly having an axial passageway extending proximally from a distal end of the transducer through at least a portion of a length of the transducer assembly, an ultrasonic waveguide having a proximal portion and a distal end, and an end effector at the distal end of the waveguide. The proximal portion of the waveguide is adapted to be operatively and selectively coupled within the axial passageway of the ultrasonic transducer such that the waveguide will transmit ultrasonic energy from the transducer to the end effector, and further wherein the waveguide is selectively coupleable within the transducer to provide at least two different effective lengths without altering the resonant frequency of the instrument.
CPC Classifications
A61B 17/320068 A61B 2017/320082 B06B 3/00
Filing Date
2023-05-15
Application No.
18197716
Claims
20
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.